When is AZmed the better choice?

Externally generated validation at scale: both fracture clearances rested on named institutional studies at University Hospitals Cleveland and SimonMed, and a 2026 study spanned 258,373 X-rays across 100 centers in 26 countries, the broadest generalization test in the fracture group. Honest performance reporting: it publishes the specificity figure that barely moved, 0.826 to 0.831, alongside the sensitivity that moved a lot, 0.865 to 0.955, rather than only the flattering number. The broadest single clearance trauma scope claim: AZtrauma is stated to be the only FDA cleared US solution covering fractures, joint effusions, and dislocations together.

When is Gleamer the better choice?

The widest deployment and distribution in the fracture group: roughly 35 million exams across more than 2,000 institutions in 45 countries, embedded through many imaging platform partners including Fujifilm, so it often arrives inside a workflow already in place. A graded confidence output rather than a binary flag: positive with a solid box above 90 percent confidence, doubt with a dotted box between 50 and 90, which helps a clinician calibrate how much to trust each mark. Broad, clearly bounded anatomical coverage across the appendicular skeleton, rib cage, and thoracolumbar spine, cleared for both adults and children.

Head-to-Head

AZmed vs Gleamer

Last VerifiedJuly 22, 2026

Verdict

These are the two closest matched fracture detection tools in the index, both AI centrality A, both FDA cleared for adult and pediatric fracture detection, both grading A on clinical evidence, both assistive, so the tiebreakers are the character of the validation and how the output is delivered. If independent, multi country validation matters most, start with AZmed, whose evidence is externally generated at unusual scale. If distribution reach and a graded confidence output that helps you calibrate trust matter more, start with Gleamer, the widest deployed fracture AI here. AZmed's clearances rested on named external studies and a 258,373 X-ray analysis across 26 countries. Gleamer runs across roughly 35 million exams at more than 2,000 institutions. Both keep the radiologist making the call.

Select AZmed if

Externally generated validation at scale: both fracture clearances rested on named institutional studies at University Hospitals Cleveland and SimonMed, and a 2026 study spanned 258,373 X-rays across 100 centers in 26 countries, the broadest generalization test in the fracture group.
Honest performance reporting: it publishes the specificity figure that barely moved, 0.826 to 0.831, alongside the sensitivity that moved a lot, 0.865 to 0.955, rather than only the flattering number.
The broadest single clearance trauma scope claim: AZtrauma is stated to be the only FDA cleared US solution covering fractures, joint effusions, and dislocations together.

Select Gleamer if

The widest deployment and distribution in the fracture group: roughly 35 million exams across more than 2,000 institutions in 45 countries, embedded through many imaging platform partners including Fujifilm, so it often arrives inside a workflow already in place.
A graded confidence output rather than a binary flag: positive with a solid box above 90 percent confidence, doubt with a dotted box between 50 and 90, which helps a clinician calibrate how much to trust each mark.
Broad, clearly bounded anatomical coverage across the appendicular skeleton, rib cage, and thoracolumbar spine, cleared for both adults and children.

Attribute Matrix

Side-by-Side

Axis	A AZmed	G Gleamer
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage

Disclosure

These are the two closest matched fracture tools in the index, both keeping the radiologist making the call, and neither publishes pricing, a security attestation, or a data residency commitment. Both are French vendors selling into US radiology, so a buyer should establish business associate terms and confirm processing location. Neither publishes a formal governance program; AZmed edges ahead only because its published validation spans more sites and countries, earning it a higher governance grade. Both also carry a chest module, so a buyer standardizing on one for trauma should confirm the specific chest indications cleared rather than assume parity. Neither publishes model architecture or a third party head to head benchmark against the other.